S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Consumers are increasingly pushing back against price increases — and winning
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
New Trump Bombshell (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Federal prosecutors accuse a New Mexico woman of fraud in oil and gas royalty case
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Consumers are increasingly pushing back against price increases — and winning
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
New Trump Bombshell (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Federal prosecutors accuse a New Mexico woman of fraud in oil and gas royalty case
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Consumers are increasingly pushing back against price increases — and winning
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
New Trump Bombshell (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Federal prosecutors accuse a New Mexico woman of fraud in oil and gas royalty case
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Consumers are increasingly pushing back against price increases — and winning
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
New Trump Bombshell (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Federal prosecutors accuse a New Mexico woman of fraud in oil and gas royalty case

Apogee Therapeutics (APGE) News Today

$34.91
-0.20 (-0.57%)
(As of 02/23/2024 ET)
SourceHeadline
MarketBeat logoApogee Therapeutics, Inc. (NASDAQ:APGE) Receives $38.33 Consensus Price Target from Brokerages
americanbankingnews.com - February 19 at 6:08 AM
MarketBeat logoApogee Therapeutics, Inc. (NASDAQ:APGE) Receives Average Recommendation of "Buy" from Brokerages
americanbankingnews.com - February 19 at 5:34 AM
marketbeat.com logoApogee Therapeutics, Inc. (NASDAQ:APGE) Given Consensus Rating of "Buy" by Analysts
marketbeat.com - February 19 at 5:24 AM
marketbeat.com logoVictory Capital Management Inc. Invests $337,000 in Apogee Therapeutics, Inc. (NASDAQ:APGE)
marketbeat.com - February 18 at 4:14 AM
marketbeat.com logoBank of New York Mellon Corp Purchases Shares of 59,660 Apogee Therapeutics, Inc. (NASDAQ:APGE)
marketbeat.com - February 9 at 4:22 AM
marketbeat.com logoApogee Therapeutics (NASDAQ:APGE) Reaches New 12-Month High at $37.49
marketbeat.com - February 8 at 11:12 AM
marketbeat.com logoVivo Capital LLC Takes Position in Apogee Therapeutics, Inc. (NASDAQ:APGE)
marketbeat.com - February 6 at 1:40 PM
marketbeat.com logoApogee Therapeutics (NASDAQ:APGE) Stock Price Up 3.2%
marketbeat.com - February 5 at 3:43 PM
marketbeat.com logoApogee Therapeutics, Inc. (NASDAQ:APGE) Receives Average Rating of "Buy" from Brokerages
marketbeat.com - January 25 at 6:36 AM
marketbeat.com logoTD Asset Management Inc Purchases Shares of 31,794 Apogee Therapeutics, Inc. (NASDAQ:APGE)
marketbeat.com - January 23 at 5:10 AM
marketbeat.com logoPlatinum Investment Management Ltd. Invests $6.04 Million in Apogee Therapeutics, Inc. (NASDAQ:APGE)
marketbeat.com - January 21 at 9:42 AM
markets.businessinsider.com logoStifel Nicolaus Keeps Their Buy Rating on Apogee Therapeutics, Inc. (APGE)
markets.businessinsider.com - January 16 at 9:31 AM
marketbeat.com logoIPO watch 2024: Which new stocks will hit the market? (APGE)
marketbeat.com - January 8 at 7:03 AM
marketbeat.com logoApogee Therapeutics (NASDAQ:APGE) Given New $44.00 Price Target at Guggenheim
marketbeat.com - January 3 at 11:43 AM
finance.yahoo.com logoApogee Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 2 at 8:53 AM
marketbeat.com logoApogee Therapeutics, Inc. (NASDAQ:APGE) Given Average Recommendation of "Buy" by Brokerages
marketbeat.com - December 31 at 6:19 AM
benzinga.com logoApogee Therapeutics Stock (NASDAQ:APGE), Analyst Ratings, Price Targets, Predictions
benzinga.com - December 22 at 3:26 PM
benzinga.com logoApogee Therapeutics Stock (NASDAQ:APGE) Dividends: History, Yield and Dates
benzinga.com - December 21 at 12:56 PM
marketbeat.com logoApogee Therapeutics (NASDAQ:APGE) Coverage Initiated at BTIG Research
marketbeat.com - December 20 at 7:10 AM
bizjournals.com logoLexington diabetes drug, device maker files for IPO — a rarity in 2023
bizjournals.com - December 15 at 1:36 PM
markets.businessinsider.com logoApogee Therapeutics, Inc.: Outshining Lebrikizumab with APG777’s Enhanced Efficacy and Quarterly Dosing Advantage
markets.businessinsider.com - November 28 at 11:14 PM
finance.yahoo.com logoWe Think Apogee Therapeutics (NASDAQ:APGE) Can Easily Afford To Drive Business Growth
finance.yahoo.com - November 21 at 6:25 PM
finance.yahoo.com logoApogee Therapeutics Inc Reports Q3 2023 Financial Results and Corporate Progress
finance.yahoo.com - November 15 at 8:59 AM
finance.yahoo.com logoApogee Highlights Corporate Progress and Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 13 at 8:20 AM
morningstar.com logoApogee Therapeutics Inc APGE
morningstar.com - November 8 at 8:59 AM
bizjournals.com logoA handful of biotechs have finally held IPOs. Will more follow?
bizjournals.com - November 2 at 8:00 AM
finance.yahoo.com logoApogee Therapeutics to Participate in Upcoming November Investor Conferences
finance.yahoo.com - October 30 at 9:34 AM
finanznachrichten.de logoApogee Therapeutics Announces IPO Of 15.625 Mln Shares To Be Priced Between $15.00 And $17.00/Share
finanznachrichten.de - October 24 at 11:58 PM
finance.yahoo.com logoApogee Announces Two Abstracts Accepted for Presentation at the 2023 European Academy of Dermatology and Venereology (EADV) Congress
finance.yahoo.com - September 27 at 10:00 AM
marketbeat.com logoApogee Therapeutics, Inc. (NASDAQ:APGE) Receives Average Recommendation of "Buy" from Analysts
marketbeat.com - September 22 at 8:12 AM
bizjournals.com logoA biotech holds a $250M IPO, stoking flames of hope for industry watchers
bizjournals.com - September 15 at 5:59 PM
finance.yahoo.com logoApogee Therapeutics to Participate at the 2023 Stifel Virtual I&I Day
finance.yahoo.com - September 14 at 10:19 AM
marketbeat.com logoQ3 2023 EPS Estimates for Apogee Therapeutics, Inc. (NASDAQ:APGE) Lifted by Analyst
marketbeat.com - August 31 at 6:11 AM
finance.yahoo.com logoParagon Therapeutics Recognizes Key Milestones and Leadership Appointment for First Spinout, Apogee Therapeutics
finance.yahoo.com - August 29 at 6:03 PM
finance.yahoo.com logoApogee Highlights Corporate Progress and Reports Second Quarter 2023 Financial Results
finance.yahoo.com - August 28 at 10:01 AM
seekingalpha.com logoApogee Therapeutics: Potential To Target Autoimmune Disorders With Less Frequent Dosing
seekingalpha.com - August 22 at 8:14 AM
seekingalpha.com logoApogee Therapeutics appoints Mark C. Mckenna as Chairman of its board
seekingalpha.com - August 21 at 3:52 PM
finance.yahoo.com logoApogee Therapeutics Appoints Mark C. McKenna, Healthcare Veteran and Former Chairman, President and CEO of Prometheus Biosciences, as Chairman of its Board
finance.yahoo.com - August 21 at 9:56 AM
marketbeat.com logoApogee Therapeutics, Inc.'s Quiet Period To Expire on August 23rd (NASDAQ:APGE)
marketbeat.com - August 16 at 1:32 AM
marketbeat.com logoApogee Therapeutics, Inc. (NASDAQ:APGE) Forecasted to Post Q2 2023 Earnings of ($0.51) Per Share
marketbeat.com - August 10 at 6:48 AM
marketbeat.com logoApogee Therapeutics (NASDAQ:APGE) Coverage Initiated at TD Cowen
marketbeat.com - August 8 at 8:42 AM
finance.yahoo.com logoApogee Announces First Participants Dosed Ahead of Schedule in Phase 1 Trial of APG777, its Novel Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
finance.yahoo.com - August 7 at 8:19 AM
msn.com logoApogee Therapeutics, Turnstone Biologics See Activist Action
msn.com - August 4 at 10:54 PM
finance.yahoo.com logoApogee Therapeutics to Participate in Upcoming August Investor Conferences
finance.yahoo.com - August 2 at 7:55 AM
barrons.com logoApogee Therapeutics Inc.
barrons.com - July 28 at 11:32 PM
investing.com logoApogee Therapeutics Inc (APGE)
investing.com - July 20 at 12:59 AM
nasdaq.com logoApogee Therapeutics Rings the Closing Bell
nasdaq.com - July 19 at 7:59 PM
finance.yahoo.com logoApogee Therapeutics, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - July 18 at 6:17 PM
Get Apogee Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APGE and its competitors with MarketBeat's FREE daily newsletter.



APGE Media Mentions By Week

APGE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

APGE
News Sentiment

0.69

0.44

Average
Medical
News Sentiment

APGE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

APGE Articles
This Week

3

1

APGE Articles
Average Week

Get Apogee Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APGE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:APGE) was last updated on 2/25/2024 by MarketBeat.com Staff